Results 71 to 80 of about 24,692 (192)

Pharmaceutical Management of Rosacea—An Australian/New Zealand Medical Dermatology Consensus Narrative

open access: yesDermatologic Therapy, Volume 2024, Issue 1, 2024.
Rosacea, a common chronic, predominantly centro‐facial dermatosis, has previously been classified into distinct subtypes with a range of morphological signs that overlap with other inflammatory skin disorders. Recently, there has been a move towards diagnosis of clinical phenotypes, largely driven by a better understanding of the pathophysiology of ...
M. Rademaker   +12 more
wiley   +1 more source

Clinical efficacy of combination treatment for advanced-stage axial diabetic optic neuropathy

open access: yesJournal of Ophthalmology, 2018
Background: There is no standard of therapy for diabetic optic neuropathy (DON) which takes into consideration the type and stage of the disease. Purpose: To assess the clinical efficacy of combined adjunct treatment with thioctic acid, a combination
M.A. Karliychuk
doaj   +1 more source

Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation

open access: yesPharmaceuticals, 2020
Effective pharmacotherapy during glaucoma treatment depends on interventions that reduce intraocular pressure (IOP) and retain the IOP lowering effect for sufficient time so as to reduce dosing frequency and enhance patient adherence.
Elissavet Taka   +6 more
doaj   +1 more source

Rescue vitrectomy with blocked artery massage and bloodletting for branch retinal artery occlusion

open access: yesIndian Journal of Ophthalmology, 2017
A 61-year-old male suffered from sudden blurred vision and superior visual field defect oculus dexter. His vision was counting fingers at 20 cm. Fundoscopy demonstrated inferior pale retina and a large embolus located at the proximal inferior retinal ...
Chun-Ju Lin   +5 more
doaj   +1 more source

Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection [PDF]

open access: yesРМЖ "Клиническая офтальмология", 2019
M. Kh. Khubetsova1, V.V. Kadyshev2, B.F. Ambalova3 1S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, Russian Federation 2Moscow Genetic Research Center, Moscow, Russian Federation 3Right-Shore Central Regional Clinical Hospital ...
M. Kh. Khubetsova   +2 more
doaj  

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension

open access: yesClinical Ophthalmology, 2008
Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj  

Aerobic exercise and intraocular pressure in normotensive and glaucoma patients

open access: yesBMC Ophthalmology, 2009
Background With the increasing number of people participating in physical aerobic exercise, jogging in particular, we considered that it would be worth knowing if there are should be limits to the exercise with regard to the intraocular pressure (IOP) of
Chatzibalis Theodosios   +5 more
doaj   +1 more source

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

open access: yesPatient Preference and Adherence, 2017
Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of ...
Anderson MS   +4 more
doaj  

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

open access: yesClinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa

open access: yesJournal of Ophthalmology, 2015
Aims. Several treatments have been proposed to slow down progression of Retinitis pigmentosa (RP), a hereditary retinal degenerative condition leading to severe visual impairment.
Marta Sacchetti   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy